• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    1.64 Down 0.02(1.20%) 4:02PM EST
    Add to Portfolio
    Prev Close:1.66
    Open:1.64
    Bid:1.60 x 300
    Ask:1.68 x 200
    1y Target Est:4.56
    Beta:1.12
    Next Earnings Date: 5-Mar-15NAVB Earnings announcement
    Day's Range:1.63 - 1.66
    52wk Range:0.97 - 2.12
    Volume:208,426
    Avg Vol (3m):1,011,770
    Market Cap:246.28M
    P/E (ttm):N/A
    EPS (ttm):-0.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBDown 1.20%246.28M
    LLYDown 1.05%74.64B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):54.06
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.23
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback